FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/01/017274 [Registered on: 25/01/2019] Trial Registered Prospectively
Last Modified On: 17/11/2019
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Examination of children with glaucoma using a new modality for sedation 
Scientific Title of Study   Evaluation of Intranasal Dexmedetomidine as a sedative agent for examination of children with pediatric glaucoma without inhalational anesthesia 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sushmita Kaushik 
Designation  Professor 
Affiliation  Adavanced Eye Centre, Postgraduate Institute of Medical Education & Research 
Address  Room No 116, Advanced Eye Centre, Postgraduate Institute of Medical Education and Research.
Sector 12
Chandigarh
CHANDIGARH
134109
India 
Phone  09814813207  
Fax  01722756112  
Email  sushmita_kaushik@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Sushmita Kaushik 
Designation  Professor 
Affiliation  Advanced Eye Centre, Postgraduate Institute of Medical Education & Research 
Address  Room No 116, Advanced Eye Centre Postgraduate Institute of Medical Education and Research
Sector 12
Chandigarh
CHANDIGARH
160012
India 
Phone  09814813207  
Fax  0172-2756112  
Email  sushmita_kaushik@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Sushmita Kaushik 
Designation  Professor 
Affiliation  Advanced Eye Centre, Postgraduate Institute of Medical Education & Research 
Address  Room No 116, Advanced Eye Center, Postgraduate Institute of Medical Education and Research
Sector 12
Chandigarh
CHANDIGARH
160012
India 
Phone  09814813207  
Fax  01722756112  
Email  sushmita_kaushik@yahoo.com  
 
Source of Monetary or Material Support  
Postgraduate Institute of Medical Education and Research, Chandigarh  
 
Primary Sponsor  
Name  Medical Education Cell Postgraduate Institute of Medical Education and Research Chandigarh 
Address  Postgraduate Institute of Medical Education and Research Sector 12 Chandigarh 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sushmita Kaushik  Postgraduate Institute of Medical Education and Research, Chandigarh  Room No 116, Advanced Eye Centre, Postgraduate Institute of Medical Education and Research
Chandigarh
CHANDIGARH 
9814813207
01722756112
sushmita_kaushik@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Postgraduate Institute of Medical Education and Research, Chandigarh  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H00-H59||Diseases of the eye and adnexa,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Dexmedetomidine  Intranasal Dexmedetomidine 3 ug/kg 
Intervention  Dexmedetomidine  Intranasal Dexmedetomidine 3.5ug/kg administered by an atomizer and examination started after 20 minutes. Maximum time to wait for effect will be 45 minutes.  
 
Inclusion Criteria  
Age From  6.00 Month(s)
Age To  6.00 Year(s)
Gender  Both 
Details  1) Children with age of 6 months to years requiring Examination under sedation following surgery for pediatric glaucoma.
2) ASA (American Society of Anaesthesiologists) physical status I/II
 
 
ExclusionCriteria 
Details  Cardiorespiratory distress
bradycardia
upper respiratory tract infection
liver disease
seizures
acute medical condition  
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
Percentage of children having successful examination without requiring rescue sedative agent at 30minutes after intranasal dexmedetomidine   30 minutes after intranasal dexmedetomidine  
 
Secondary Outcome  
Outcome  TimePoints 
1.Mean time of onset of adequate sedation score (Ramsay’s score)
2.Sedation scores at 10 minutes, 20 minutes and 30 minutes after administration
3.Need of rescue drug if no sedation after 30 minutes
4. Surgeon satisfaction score for completion of procedure (IOP, Corneal diameter, ophthalmoscopy)
5. Discharge time
6. Adverse effects
7. Parents satisfaction
 
Sedation score will be assessed at 10, 20 and 30 minutes after administration of the drug. 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "60"
Final Enrollment numbers achieved (India)="60" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/01/2019 
Date of Study Completion (India) 10/04/2019 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 10/04/2019 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Not applicable 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

It is a randomized, prospective, interventional study and will be conducted at Advanced Eye Centre (AEC), Department of Ophthalmology, PGIMER, Chandigarh in collaboration with department of Anaesthesia. Patients will be divided in two groups: Group 3 ug/kg, Group 3.5µg /kg.

Children will be given intranasal dexmedetomidine (3/3.5µg/kg) using mucosal atomization device. The time of drug administration will be noted. Ramsay sedation score will be assessed after 10, 20 and 30 min thereafter. 

When adequate sedative score is achieved, ophthalmic examination will be performed. If adequate sedation in not achieved then rescue sedation will be used and recorded. 

Patient will be discharged after Revised Alderte Score of 9-10 is reached and the time of recovery will be noted. A note will be made of any complications like bradycardia, arrythmias, desaturation, reduction in respiratory rate will be made.  Parents satisfaction scoring will be done as good/ fair/poor.


 
Close